Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

Rachel Nemoyer; Arindam Mondal; Mehul Vora; Elaine Langenfeld; Danea Glover; Michael Scott; Lauren Lairson; Christopher Rongo; David J. Augeri; Youyi Peng; Salma K. Jabbour; John Langenfeld

doi:10.1186/s12964-019-0469-5

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

Rachel Nemoyer, Arindam Mondal, Mehul Vora, Elaine Langenfeld, Danea Glover, Michael Scott, Lauren Lairson, Christopher Rongo, David J. Augeri, Youyi Peng, Salma K. Jabbour, John Langenfeld

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Original language	English (US)
Article number	150
Journal	Cell Communication and Signaling
Volume	17
Issue number	1
DOIs	https://doi.org/10.1186/s12964-019-0469-5
State	Published - Nov 19 2019

All Science Journal Classification (ASJC) codes

Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1186/s12964-019-0469-5

Cite this

Nemoyer, R., Mondal, A., Vora, M., Langenfeld, E., Glover, D., Scott, M., Lairson, L., Rongo, C., Augeri, D. J., Peng, Y., Jabbour, S. K., & Langenfeld, J. (2019). Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein. Cell Communication and Signaling, 17(1), Article 150. https://doi.org/10.1186/s12964-019-0469-5

@article{e418be7ca31c4e6f8a60d421c1de701b,

title = "Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein",

author = "Rachel Nemoyer and Arindam Mondal and Mehul Vora and Elaine Langenfeld and Danea Glover and Michael Scott and Lauren Lairson and Christopher Rongo and Augeri, {David J.} and Youyi Peng and Jabbour, {Salma K.} and John Langenfeld",

year = "2019",

month = nov,

day = "19",

doi = "10.1186/s12964-019-0469-5",

language = "English (US)",

volume = "17",

journal = "Cell Communication and Signaling",

issn = "1478-811X",

publisher = "BioMed Central",

number = "1",

}

Nemoyer, R, Mondal, A, Vora, M, Langenfeld, E, Glover, D, Scott, M, Lairson, L, Rongo, C, Augeri, DJ, Peng, Y, Jabbour, SK & Langenfeld, J 2019, 'Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein', Cell Communication and Signaling, vol. 17, no. 1, 150. https://doi.org/10.1186/s12964-019-0469-5

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein. / Nemoyer, Rachel; Mondal, Arindam; Vora, Mehul et al.
In: Cell Communication and Signaling, Vol. 17, No. 1, 150, 19.11.2019.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

AU - Nemoyer, Rachel

AU - Mondal, Arindam

AU - Vora, Mehul

AU - Langenfeld, Elaine

AU - Glover, Danea

AU - Scott, Michael

AU - Lairson, Lauren

AU - Rongo, Christopher

AU - Augeri, David J.

AU - Peng, Youyi

AU - Jabbour, Salma K.

AU - Langenfeld, John

PY - 2019/11/19

Y1 - 2019/11/19

UR - http://www.scopus.com/inward/record.url?scp=85075323090&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075323090&partnerID=8YFLogxK

U2 - 10.1186/s12964-019-0469-5

DO - 10.1186/s12964-019-0469-5

M3 - Article

C2 - 31744505

AN - SCOPUS:85075323090

SN - 1478-811X

VL - 17

JO - Cell Communication and Signaling

JF - Cell Communication and Signaling

IS - 1

M1 - 150

ER -

Targeting bone morphogenetic protein receptor 2 sensitizes lung cancer cells to TRAIL by increasing cytosolic Smac/DIABLO and the downregulation of X-linked inhibitor of apoptosis protein

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this